Affymetrix Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
The Google Of Genetic Testing Looks Like A Buy Right Now
Article By: Steve Alexander
Saturday, April 23, 2016 12:15 PM EDT
You don't often get good opportunities to buy into dominant players in enormous future growth markets at reasonable prices, but I believe that is exactly what we are getting right now with Illumina.
In this article: ILMN, AFFX, PACB
Read
Week In Review: Origin-Centrillion Offers $1.5 Billion For Affymetrix
Article By: ChinaBio® Today
Saturday, March 26, 2016 4:16 PM EDT
Origin Technologies, a US company with deep China connections, has raised its bid to acquire Affymetrix, a US microarray company, to $17 per share.
In this article: AFFX Also: TSRO, TMO, AVEO
Read
On The Fly: Pre-market Movers
Article By: The Fly
Monday, March 21, 2016 9:23 AM EDT
Valspar up 25.6% after Sherwin-Williams will acquire the company for $113 per share in an all cash deal. Starwood Hotels up 5.9% after Marriott and Starwood signed an amended merger agreement.
In this article: MAR, SHW, VAL, X, BMRN, AFFX, INTC, TSLA, WLRH
Read
J.P.Morgan Healthcare Conference #1: Investors Move Into Life Science Stocks-Bouncing Off The Bottom
Article By: Rod Raynovich
Tuesday, January 12, 2016 8:28 PM EDT
We have a long way to recover in this bear market. The IBB​ touched near 52 week lows yesterday at $287 and is currently at $296 after a failed bounce then a recovery. We are down about 12% over five days.
In this article: ALR, JPM, NGS, TMO, RHHBY, CPHD, IBB, ILMN, ABAX, AFFX, QGEN
Read
Thermo Fisher Scientific Inc. Acquires Affymetrix In A Deal Valued At $1.3 Billion
Article By: Terry Chrisomalis
Saturday, January 9, 2016 2:52 PM EDT
On Friday Shares of Affymetrix surged by 50% in after-hours trade after Thermo Fisher Scientific agreed to buy it for $1.3 billion in an all cash type deal.
In this article: TMO, AFFX
Read

Latest Tweets for $AFFX

No tweets yet!

PARTNER HEADLINES